JANSSEN ABIRATERONE abiraterone acetate 500 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

janssen abiraterone abiraterone acetate 500 mg film-coated tablet blister pack

janssen-cilag pty ltd - abiraterone acetate, quantity: 500 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; sodium lauryl sulfate; silicified microcrystalline cellulose; hypromellose; magnesium stearate; silicon dioxide; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - janssen abiraterone is indicated in combination with prednisone or prednisolone for the treatment of: ? newly diagnosed high-risk metastatic hormone sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (adt), or ? patients with metastatic advanced prostate cancer (castration resistant prostate cancer, mcrpc) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (adt) or ? patients with mcrpc who have received prior chemotherapy containing a taxane.

JANSSEN ABIRATERONE abiraterone acetate 250 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

janssen abiraterone abiraterone acetate 250 mg tablet bottle

janssen-cilag pty ltd - abiraterone acetate, quantity: 250 mg - tablet - excipient ingredients: colloidal anhydrous silica; povidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; sodium lauryl sulfate; croscarmellose sodium - janssen abiraterone is indicated in combination with prednisone or prednisolone for the treatment of: ? newly diagnosed high-risk metastatic hormone sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (adt), or ? patients with metastatic advanced prostate cancer (castration resistant prostate cancer, mcrpc) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (adt) or ? patients with mcrpc who have received prior chemotherapy containing a taxane.

NAT-ABIRATERONE TABLET Canada - English - Health Canada

nat-abiraterone tablet

natco pharma (canada) inc - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg - antineoplastic agents

MAR-ABIRATERONE TABLET Canada - English - Health Canada

mar-abiraterone tablet

marcan pharmaceuticals inc - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg - antineoplastic agents

MAR-ABIRATERONE TABLET Canada - English - Health Canada

mar-abiraterone tablet

marcan pharmaceuticals inc - abiraterone acetate - tablet - 500mg - abiraterone acetate 500mg - antineoplastic agents

TEVA-ABIRATERONE TABLET Canada - English - Health Canada

teva-abiraterone tablet

teva canada limited - abiraterone acetate - tablet - 500mg - abiraterone acetate 500mg - antineoplastic agents

TEVA-ABIRATERONE TABLET Canada - English - Health Canada

teva-abiraterone tablet

teva canada limited - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg - antineoplastic agents

ABIRATERONE TABLET Canada - English - Health Canada

abiraterone tablet

jamp pharma corporation - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg

ABIRATERONE TABLET Canada - English - Health Canada

abiraterone tablet

jamp pharma corporation - abiraterone acetate - tablet - 500mg - abiraterone acetate 500mg

APO-ABIRATERONE FILM COATED TABLETS Canada - English - Health Canada

apo-abiraterone film coated tablets

apotex inc - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg - antineoplastic agents